QIAGEN Digital Insights Monday, February 24, 2020
Wednesday, March 25, hear from Dr. Anthony M Magliocco, CEO and Founder of Protean BioDiagnostics, as he discusses the application…
QIAGEN Digital Insights Monday, February 4, 2019
As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…